Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Headlines

(image_jungle/iStock via Getty Images Plus)

Cancer drug developer aims to transform treatment

A leader from clinical-stage pharma firm NuCana shares promising results for its ProTides therapies and hopes the drugs can elevate outcomes for patients.

Interline Therapeutics lands $92m to map, correct dysfunctional proteins

The company reportedly will utilize the investment funding to expand its research platform, and to advance six of its preclinical therapeutic programs.

Content provided by PharmaNutra Spa

Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional supplement

An investigation was recently conducted in Italy on around 200 post-Covid patients suffering from persistent fatigue, who were advised to take Apportal for 28 days

Drug developer uses RWE to research psychedelic therapies

The UK-based development and research firm hopes to accelerate patient access to psychedelic therapies for treatment of various mental health conditions.

Clinical study shows drug has COVID-19 treatment potential

Interim data reportedly indicates Noxopharm’s Veyonda could be effective in treating cytokine storm, an inflammatory effect associated with moderate cases.

Content provided by FedEx

Building resilient healthcare supply chains post-pandemic

COVID-19 drastically reconfigured APAC healthcare supply chains in the past year. So what’s next?

Getting cancer trials back on track after COVID-19

A leader from oncology trial insights and analysis specialist Inteliquet discusses how cancer studies can recover after the impact of the global pandemic.